Equipping The Next-Generation Rare Disease Patient Advocate

Charlene Son Rigby, who will take the helm of Global Genes following its merger with RARE-X, discusses the integration of the two organizations, the convergence of her personal and professional lives, and how the combination of the two organization will provide next-generation rare disease advocates the tools and resources they need to accelerate their drive for treatments.